Trial Details

Recruiting
Basic Information
Clinical ID c2093
Identifier IRCT20231009059671N1
Trial Title Evaluation the effectiveness of acupuncture on Inflammatory Bowel Disease patients
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Condition 1: crohn's disease. Condition 2: ulcerative colitis. Crohn's disease [regional enteritis] Ulcerative colitis
Interventions Intervention 1: Intervention group: Patients in the intervention group receive acupuncture treatment twice a week for eight weeks and a total of 16 sessions. Each acupuncture session lasts about 30 minutes. The points include KID3(taixi), LIV3(taichong), ST25(tianshu), ST40(fenglong), ST36(zusanli), LI4(hegu), LI11(quchi), SP4(gongsun), SP6(sanyinjiao), SP9(yinlingchuan). ) , SP15(daheng) , BL18(ganshu) , BL20(pishu) , BL23(shenshu) , BL25(dachangshu) , PC6(neiguan) , HT7(shenmen) , CV4(guanyuan) , CV6(qihai) , CV9(shuifen) ), CV12(zhongwan), GV20(baihui), GV4(mingmen) with needles of size 0.25*40 and is inserted to the depth of deqi. Intervention 2: Control group: Patients in the control group, like the intervention group, receive 16 sham acupuncture sessions twice a week for eight weeks. Each session lasts about 30 minutes. The points with a distance from the acupuncture points in non-acupuncture point and non-meridian places are injected shallowly with the same number and size of needles as the intervention group.
Participant Information
Sponsor Mashhad University of Medical Sciences
City -
Country/Region Iran
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT, TEENAGER
Study Design
Study Type interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -